Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prescribing in pregnancy. Thyroid disease.

W Burr

    Clinics in Obstetrics and Gynaecology
    |June 1, 1986
    PubMed
    Summary

    Thyroid disease in pregnancy requires careful monitoring for both mother and child. While maternal thyroid issues often improve during pregnancy, fetal risks from medications and antibodies necessitate close postpartum observation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Report on the Development of the Advanced Encryption Standard (AES).

    Journal of research of the National Institute of Standards and Technology·2016
    Same author

    [Which factors have an impact on levetiracetam serum concentrations? An analysis in 163 patients with epilepsy].

    Der Nervenarzt·2010
    Same author

    Which patients become seizure free with antiepileptic drugs? An observational study in 821 patients with epilepsy.

    Acta neurologica Scandinavica·2007
    Same author

    Course of chronic focal epilepsy resistant to anticonvulsant treatment.

    Seizure·2001
    Same author

    Precipitating factors and therapeutic outcome in epilepsy with generalized tonic-clonic seizures.

    Acta neurologica Scandinavica·2000
    Same author

    Advances in telecommunications concerning epilepsy.

    Epilepsia·2000

    Area of Science:

    • Endocrinology
    • Obstetrics
    • Neonatology

    Background:

    • Thyroid disease management during pregnancy balances maternal and fetal well-being.
    • Maternal thyroid function often improves during pregnancy, but postpartum relapses are common.
    • Fetal and neonatal risks arise from maternal treatments and transplacental antibody transfer.

    Purpose of the Study:

    • To review the potential risks of thyroid disease and its treatment during pregnancy for the fetus and neonate.
    • To highlight the importance of monitoring fetal and neonatal thyroid status.
    • To emphasize the need for multidisciplinary collaboration in managing thyroid disease during pregnancy.

    Main Methods:

    • Review of existing literature on thyroid disease in pregnancy.
    • Analysis of risks associated with antithyroid drugs and maternal antibodies.
    • Discussion of fetal and neonatal complications, including goiter, hypothyroidism, and hyperthyroidism.

    Main Results:

    • Antithyroid drugs can cause fetal goiter and airway obstruction, and mild neonatal hypothyroidism.
    • Maternal thyroid antibodies may lead to neonatal hypothyroidism and thyroid dysgenesis.
    • Neonatal hyperthyroidism presents significant morbidity, mortality, and potential long-term skeletal effects.

    Conclusions:

    • Close monitoring of mother, fetus, and neonate throughout pregnancy and the postpartum period is crucial.
    • Multidisciplinary collaboration among obstetricians, endocrinologists, and pediatricians is essential for optimal outcomes.
    • Most pregnancies with thyroid disease result in successful outcomes with appropriate management and monitoring.

    Related Experiment Videos